Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Prothena Corp
(NQ:
PRTA
)
13.81
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 12, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Prothena Corp
< Previous
1
2
3
4
5
6
7
8
Next >
Prothena Corp's Earnings Outlook
August 02, 2023
Via
Benzinga
Prothena to Report Second Quarter 2023 Financial Results on August 3
July 27, 2023
From
Prothena Corporation plc
Via
Business Wire
Prothena Presents New Research in the Treatment of Alzheimer’s Disease at Alzheimer’s Association International Conference® 2023 (AAIC®)
July 17, 2023
From
Prothena Corporation plc
Via
Business Wire
Prothena to Present New Data from Alzheimer’s Disease Programs at Alzheimer’s Association International Conference® 2023 (AAIC®)
July 11, 2023
From
Prothena Corporation plc
Via
Business Wire
Expert Ratings for Prothena Corp
July 11, 2023
Via
Benzinga
8 Analysts Have This to Say About Prothena Corp
June 21, 2023
Via
Benzinga
Prothena Announces Bristol Myers Squibb Opt-in for Worldwide Rights of PRX005, a Novel Anti-MTBR-Tau Antibody
July 10, 2023
From
Prothena Corporation plc
Via
Business Wire
Prothena Announces Phase 3 VITAL Clinical Trial Results Published in Blood Showing Survival Benefit in Patients with Mayo Stage IV AL Amyloidosis Treated with Birtamimab
June 27, 2023
From
Prothena Corporation plc
Via
Business Wire
Prothena to Participate in Jefferies 2023 Healthcare Conference
June 02, 2023
From
Prothena Corporation plc
Via
Business Wire
Looking Into Prothena Corp's Return On Capital Employed
May 16, 2023
Via
Benzinga
Recap: Prothena Corp Q1 Earnings
May 04, 2023
Via
Benzinga
Prothena Corp Earnings Preview
May 03, 2023
Via
Benzinga
Prothena Announces Appointment of Billy Dunn, M.D., to its Board of Directors
May 16, 2023
From
Prothena Corporation plc
Via
Business Wire
Prothena Reports First Quarter 2023 Financial Results and Business Highlights
May 04, 2023
From
Prothena Corporation plc
Via
Business Wire
10 Health Care Stocks Whale Activity In Today's Session
May 04, 2023
Via
Benzinga
Another Sucess In Alzheimer’s Disease
May 03, 2023
Eli Lily reported a successful phase III trial of donanemab in Alzheimer’s Disease. How does it differentiate from lecanemab and what does it mean for beta-amyloid treatments?
Via
Talk Markets
Where Prothena Corp Stands With Analysts
April 24, 2023
Via
Benzinga
The Latest Analyst Ratings for Prothena Corp
April 03, 2023
Via
Benzinga
Earnings Outlook For Prothena Corp
February 22, 2023
Via
Benzinga
Prothena to Report First Quarter 2023 Financial Results on May 4
April 27, 2023
From
Prothena Corporation plc
Via
Business Wire
Prothena to Participate in 2023 Bank of America Healthcare Conference
April 24, 2023
From
Prothena Corporation plc
Via
Business Wire
Walgreens and Prothena Partner to Increase Access and Enrollment in Alzheimer’s Disease Clinical Trial
April 13, 2023
From
Walgreens
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For April 24, 2023
April 24, 2023
Via
Benzinga
Prothena Presents New Preclinical Data Supporting Best-in-Class Profile of PRX012, a Next-Generation Anti-Amyloid Beta Antibody, at AD/PD 2023
March 31, 2023
From
Prothena Corporation plc
Via
Business Wire
Prothena to Participate in Stifel 2023 Virtual CNS Days
March 21, 2023
From
Prothena Corporation plc
Via
Business Wire
Biotech Sector Working Fast to Combat Alzheimer’s Disease Cases That are Set to Explode
March 15, 2023
FN Media Group Presents USA News Group News Commentary Vancouver, BC – March 15, 2023 – USA News Group – According to a 2022 study of more than 6 million patients 65 and older, the risk factor for...
Via
FinancialNewsMedia
Exposures
COVID-19
Prothena to Highlight Next Generation Treatments for Alzheimer’s and Parkinson’s Disease at the AD/PD 2023 Meeting
March 14, 2023
From
Prothena Corporation plc
Via
Business Wire
Prothena Reports Fourth Quarter and Full Year 2022 Financial Results, and Provides Financial Guidance and Business Highlights
February 23, 2023
From
Prothena Corporation plc
Via
Business Wire
Prothena to Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
February 16, 2023
From
Prothena Corporation plc
Via
Business Wire
Earnings Scheduled For February 23, 2023
February 23, 2023
Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.